THE NASOPHARYNGEAL CARCINOMA (NPC) - LONG-TERM SURVEYS OF THE IMMUNITY OF PATIENTS WITH NPC

被引：1
|
作者：
BERTRAM, G
SESTERHENN, K
WUSTROW, J
KRUEGER, GRF
机构：
来源：
ARCHIVES OF OTO-RHINO-LARYNGOLOGY-ARCHIV FUR OHREN-NASEN-UND KEHLKOPFHEILKUNDE | 1980年 / 227卷 / 3-4期
关键词：
D O I：
10.1007/BF00467588
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
引用
收藏
页码：511 / 514
页数：4
相关论文
共 50 条
  • [31] A STUDY OF THE TNM STAGING SYSTEM FOR NASOPHARYNGEAL CARCINOMA (NPC)
    李长青
    廖玲霞
    ChineseJournalofCancerResearch, 1996, (02) : 148 - 151
  • [32] COMPLEX SEGREGATION ANALYSIS OF NASOPHARYNGEAL CARCINOMA (NPC) IN TAIWAN
    WANG, YF
    CHEN, CJ
    HARRIS, EL
    KING, TM
    HSU, MM
    DIEHL, SR
    BEATY, TH
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 995 - 995
  • [33] Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma (NPC)
    Ciuleanu, E
    Ciuleanu, TE
    Popita, V
    Todor, N
    Fodor, A
    Ghilezan, N
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S162 - S162
  • [34] EXPERIMENTAL STUDIES ON SPECIFIC IMMUNOTHERAPY IN NASOPHARYNGEAL CARCINOMA (NPC)
    ARNOLD, W
    VOSTEEN, KH
    ARCHIVES OF OTO-RHINO-LARYNGOLOGY-ARCHIV FUR OHREN-NASEN-UND KEHLKOPFHEILKUNDE, 1980, 229 (01): : 5 - 11
  • [35] EPIDEMIOLOGIC, ETIOLOGIC AND IMMUNOLOGICAL ASPECTS OF NASOPHARYNGEAL CARCINOMA [NPC]
    GASTPAR, H
    WILMES, E
    WOLF, H
    JOURNAL OF MEDICINE, 1981, 12 (04) : 257 - 284
  • [36] Experience in the treatment of 98 patients (pts) with nasopharyngeal carcinoma (NPC):: Long term follow-up and analysis of prognostic factors.
    Gaspar, C
    Zapater, E
    Climent, MA
    Ferrandis, E
    Chust, ML
    Vendrell, JB
    Mengual, JL
    Muñoz, MA
    Arribas, L
    Guillem, V
    ANNALS OF ONCOLOGY, 2000, 11 : 93 - 93
  • [37] The Role of Genetic Pathways in the Development of Chemoradiation Resistance in Nasopharyngeal Carcinoma (NPC) Patients
    Mat Lazim, Norhafiza
    Che Lah, Che Ismail
    Wan Juhari, Wan Khairunnisa
    Sulong, Sarina
    Zilfalil, Bin Alwi
    Abdullah, Baharudin
    GENES, 2021, 12 (11)
  • [38] IGFBP-6, a novel prognostic biomarker in nasopharyngeal carcinoma (NPC) patients
    Lu, Yi
    Chen, Qiuyan
    Qi, Weici
    Hong, Minghuang
    Mizokami, Atsushi
    Keller, Evan
    Zhang, Jian
    CANCER RESEARCH, 2011, 71
  • [39] Active immunotherapy with anti-idiotypic antibody for patients with nasopharyngeal carcinoma (NPC)
    Li, GC
    Xie, L
    Zhou, GH
    Zhu, JG
    Hu, JY
    Sun, QB
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2002, 17 (06) : 673 - 679
  • [40] A phase II study of axitinib in patients with recurrent or metastatic nasopharyngeal carcinoma (NPC).
    Hui, Edwin Pun
    Ma, Brigette
    Mo, Frankie
    Kam, Michael K. M.
    Chan, Stephen Lam
    Loong, Herbert H. F.
    Ho, Rosalie
    Leung, Sing Fai
    King, Ann Dorothy
    Wang, Ki
    Ahuja, Anil Tejbhan
    Chan, Charles
    Hui, Connie W. C.
    Wong, Chi Hang
    Chan, Anthony T. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345